Loading...

PerCP/Cyanine5.5 anti-mouse Ly-6C Antibody

Pricing & Availability
Clone
HK1.4 (See other available formats)
Regulatory Status
RUO
Other Names
Lymphocyte antigen 6 complex, locus C
Isotype
Rat IgG2c, κ
Ave. Rating
Submit a Review
Product Citations
publications
HK1dot4_PerCPCy55_061909.jpg
C57BL/6 bone marrow cells stained with HK1.4 PerCP/Cyanine5.5
  • HK1dot4_PerCPCy55_061909.jpg
    C57BL/6 bone marrow cells stained with HK1.4 PerCP/Cyanine5.5
Compare all formats See PerCP/Cyanine5.5 spectral data
Cat # Size Price Quantity Check Availability Save
128011 25 µg 141 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
128012 100 µg 335 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Most hematopoietic cells express one or more members of Ly-6 family. The expression of Ly-6 varies with development stage and activation. Ly-6C is a 14-17 kD GPI-linked surface protein expressed on mouse monocyte/macrophage cells, endothelial cells, neutrophils, and some T cell subsets. Ly-6C is reported to be an indicator of memory CD8+ T cells.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
L3 cloned CTL cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PerCP/Cyanine5.5 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cyanine5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Application Notes

Clone HK1.4 does not block the binding of clone RB6-8C58.

Additional reported applications (for relevant formats of this clone) include: in vitro activation of T cells1-3 and immunohistochemistry of frozen sections4.

Application References

(PubMed link indicates BioLegend citation)
  1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819. (Activ)
  2. Herold KC, et al. 1990. Diabetes 39:815. (Activ)
  3. Havran WL, et al. 1988. J. Immunol. 140:1034 (Activ)
  4. Flanagan K, et al. 2008. J. Immunol. 180:3874. (IHC)
  5. Makaroff LE, et al. 2009. P. Natl. Acad. Sci. USA 106:4799. (FC)
  6. Zuber J, et al. 2009. Genes Dev. 23:877. (FC) PubMed
  7. Ribechini E, et al. 2009. Eur. J. Immunol. 39:3538.
  8. Ma C, et al. 2012. J. Leukoc. Biol. 92:1199.
  9. Watson NB, et al. 2015. J Immunol. 194:2796. PubMed
Product Citations
  1. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  2. Turecamo SE, et al. 2018. Matrix Biol. 67:01:00. PubMed
  3. Cohen K, et al. 2021. Cell Rep. 37:110026. PubMed
  4. Kang H, et al. 2022. Adv Mater. 34:e2106500. PubMed
  5. Dolfi B, et al. 2022. Cell Rep. 39:110949. PubMed
  6. Simpson AP, et al. 2022. Cell Rep. 40:111099. PubMed
  7. Kang J, et al. 2023. JCI Insight. 8: . PubMed
  8. Schick J, et al. 2023. Elife. 12: . PubMed
  9. Tunali G, et al. 2023. J Clin Invest. :. PubMed
  10. Awida Z, et al. 2022. Int J Mol Sci. 23:. PubMed
  11. Asare-Bediako B, et al. 2022. Cells. 11:. PubMed
  12. Olofsen PA, et al. 2022. Cells. 11:. PubMed
  13. Banerjee K, et al. 2023. Eur J Immunol. 53:e2250161. PubMed
  14. van Elsas MJ, et al. 2023. J Immunother Cancer. 11:. PubMed
  15. Garabuczi É, et al. 2023. Front Immunol. 14:1139204. PubMed
  16. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  17. Park JA, et al. 2023. J Immunother Cancer. 11:. PubMed
  18. Solier S, et al. 2023. Nature. 617:386. PubMed
  19. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  20. Marchelletta RR, et al. 2021. J Clin Invest. 131:. PubMed
  21. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  22. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  23. Hutter K, et al. 2022. Front Immunol. 13:967914. PubMed
  24. Gallizioli M, et al. 2020. Cell Rep. 33:108291. PubMed
  25. Ballesteros I, et al. 2014. J Vis Exp. 94: 52031. PubMed
  26. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  27. Fachi JL et al. 2019. Cell reports. 27(3):750-761 . PubMed
  28. Jong RM, et al. 2022. J Immunol. 208:407. PubMed
  29. Tang L, et al. 2021. Oncol Lett. 22:605. PubMed
  30. Israelow B, et al. 2020. bioRxiv. . PubMed
  31. Gonalves S, et al. 2021. Cell Reports. 34(11):108860. PubMed
  32. Zhang K, et al. 2018. PLoS Pathog. 14:e1006925. PubMed
  33. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  34. Leach SM, et al. 2020. Cell Rep. 33:108337. PubMed
  35. Yilmaz B, et al. 2021. Cell Host Microbe. 29(4):650-663.e9. PubMed
  36. Song J, et al. 2021. J Am Heart Assoc. 10:e017329. PubMed
  37. Mylonas K, et al. 2015. Immunobiology. 220: 924-933. PubMed
  38. Huard A, et al. 2021. J Immunol. 206:1058. PubMed
  39. Demars A, et al. 2021. PLoS Pathog. 17:e1009887. PubMed
  40. Yang Y, et al. 2020. Cell Death Discov. 0.293055556. PubMed
  41. Rao S, et al. 2017. Cell. 168(3):503-516.e12. PubMed
  42. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  43. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  44. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  45. Han YH, et al. 2021. Science. 373:. PubMed
  46. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  47. Zhou Z, et al. 2019. Oxid Med Cell Longev. 2019:1209307. PubMed
  48. McCreedy DA et al. 2018. eNeuro. 5(4) pii: ENEURO. PubMed
  49. Jeljeli M, et al. 2020. Cell Rep. 33:108325. PubMed
  50. Zhang Y, et al. 2015. PLoS Pathog. 11: e1005167. PubMed
  51. Stutchfield B, et al. 2015. Gastroenterology. 149: 1896-1909.e14. PubMed
  52. Lagares D, et al. 2017. Sci Transl Med. 9:eaal3765. PubMed
  53. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  54. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  55. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  56. Honarpisheh P, et al. 2020. J Neuroinflammation. 0.9625. PubMed
  57. Tanaka T, et al. 2015. J Immunol. 194:2004. PubMed
  58. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  59. Horn KJ, et al. 2022. Nat Commun. 13:3321. PubMed
  60. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  61. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  62. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  63. Golden TN, et al. 2022. Front Pharmacol. 12:761496. PubMed
  64. Panea C, et al. 2021. Commun Biol. 4:913. PubMed
  65. Brigas HC, et al. 2021. Cell Reports. 36(9):109574. PubMed
  66. Paiva-Oliveira E, et al. 2017. Histochem Cell Biol. 10.1007/s00418-017-1556-6. PubMed
  67. Medler TR et al. 2018. Cancer cell. 34(4):561-578 . PubMed
  68. Cosentino K, et al. 2022. Mol Cell. 82:933. PubMed
  69. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  70. Zeng W, et al. 2021. STAR Protocols. 2(1):100361. PubMed
  71. Williams JW, et al. 2017. Circ Res. 121:662. PubMed
  72. Landon J Edgar et al. 2018. Cell chemical biology. 26(1):131-136 . PubMed
  73. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  74. Rashid MH, et al. 2021. Oncol Rep. 45:1171. PubMed
  75. Blriot C, et al. 2021. Immunity. :. PubMed
  76. Ermert D, et al. 2016. PLoS Pathog. 11: 1005043. PubMed
  77. Jamali A, et al. 2020. Cell Reports. 32(9):108099. PubMed
  78. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  79. Ali S, et al. 2021. PLoS One. 16:e0246646. PubMed
  80. Nuro-Gyina PK, et al. 2021. J Immunol. 207:868. PubMed
  81. Yang Y, et al. 2020. Cell Death Discov. 6:62. PubMed
  82. Ioannidis L, et al. 2016. J Immunol. 196: 1227 - 1238. PubMed
  83. Dahlgren MW et al. 2019. Immunity. 50(3):707-722 . PubMed
  84. Pinho–Ribeiro FA, et al. 2018. Cell. 173:1083. PubMed
  85. Matsumura T, et al. 2022. Nat Commun. 13:7064. PubMed
  86. Hadas R, et al. 2020. JCI Insight. 5:00. PubMed
  87. Teo T, et al. 2015. J Virol. 89: 7955-7969. PubMed
  88. Budai Z, et al. 2021. Cells. 10:. PubMed
  89. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  90. Kumari P, et al. 2021. Cell Reports. 35(3):109012. PubMed
  91. Fontana MF, et al. 2015. Parasite Immunol. 37: 470-478. PubMed
  92. Klein O, et al. 2019. J Allergy Clin Immunol. 144:1074. PubMed
  93. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  94. Zhu YP et al. 2018. Cell reports. 24(9):2329-2341 . PubMed
  95. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  96. Nishio H, et al. 2020. Regen Ther. 14:262. PubMed
  97. Rustenhoven J, et al. 2021. Cell. 184(4):1000-1016.e27. PubMed
  98. Huo M, et al. 2017. FASEB J. 10.1096/fj.201601030R. PubMed
  99. Hendrikx S et al. 2019. Cell reports. 26(5):1227-1241 . PubMed
  100. Yin X, et al. 2020. Cell Rep. 33:108278. PubMed
  101. Foster G, et al. 2015. J Immunol. 195: 5380 - 5392. PubMed
  102. Yajjala V, et al. 2016. J Immunol. 196: 4196 - 4203. PubMed
  103. Walsh CM, et al. 2019. Elife. 8:e48448. PubMed
  104. Lei Y, et al. 2021. Sci Adv. 7:. PubMed
  105. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  106. Freed-Pastor WA, et al. 2021. Cancer Cell. 39:1342. PubMed
  107. Heuslein J, et al. 2016. Sci Rep. 6: 27029. PubMed
  108. Jiang Y, et al. 2015. MBio. 6: e01426-15. PubMed
  109. Valdearcos M et al. 2017. Cell metabolism. 26(1):185-197 . PubMed
  110. Orr MT, et al. 2019. NPJ Vaccines. 4:1. PubMed
  111. Sadtler K, et al. 2017. Tissue Eng Part A. 23:1044. PubMed
  112. Ioanna E Galani et al. 2017. Immunity. 46(5):875-890 . PubMed
  113. Ikezu S, et al. 2021. Mol Psychiatry. 26:1808. PubMed
  114. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  115. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  116. Al-Zaeed N, et al. 2021. Cell Death Dis. 12:611. PubMed
  117. Gangoso E, et al. 2021. Cell. 184:2454. PubMed
  118. Boguslawski KM, et al. 2020. Sci Adv. 6:eaax7515. PubMed
  119. Joshi JC, et al. 2020. Cell Rep. 30:4096. PubMed
  120. Deniset JF et al. 2019. Immunity. 51(1):131-140 . PubMed
  121. Yáñez A et al. 2017. Immunity. 47(5):890-902 . PubMed
  122. Avgustinova A, et al. 2021. Cell Stem Cell. . PubMed
  123. Steinmetz O, et al. 2016. J Infect Dis. 10.1093/infdis/jiv763. PubMed
  124. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
RRID
AB_1659242 (BioLegend Cat. No. 128011)
AB_1659241 (BioLegend Cat. No. 128012)

Antigen Details

Structure
14-17 kD protein (134 amino acids), member of the Ly-6 family of GPI linked protein. Ly6 family members share structure homology throughout a distinctive cystein rich protein domain that incorporates O-linked carbohydrates.
Distribution

Ly-6C is expressed primarily on bone marrow myeloid populations, monocytes/macrophages, neutrophils, endothelial cells, and some T cell subsets. Ly-6C is also a marker of memory CD8+ T cells.

Cell Type
Endothelial cells, Macrophages, Monocytes, Neutrophils, T cells
Biology Area
Immunology
Molecular Family
CD Molecules
Antigen References

1. Jutila MA, et al. 1988. Eur. J. Immunol. 18:1819.
2. Cerwenka A, et al. 1998. J. Immunol. 161:97.

Gene ID
17067 View all products for this Gene ID
UniProt
View information about Ly-6C on UniProt.org

Related FAQs

How stable is PerCP/Cyanine5.5 tandem as compared to PerCP alone?

PerCP/Cyanine5.5 is quite photostable and also better than PerCP alone in withstanding fixation.

Other Formats

View All Ly-6C Reagents Request Custom Conjugation
Description Clone Applications
Pacific Blue™ anti-mouse Ly-6C HK1.4 FC
APC anti-mouse Ly-6C HK1.4 FC
Purified anti-mouse Ly-6C HK1.4 FC,IHC-F
Biotin anti-mouse Ly-6C HK1.4 FC
FITC anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 647 anti-mouse Ly-6C HK1.4 FC
PE anti-mouse Ly-6C HK1.4 FC
PerCP/Cyanine5.5 anti-mouse Ly-6C HK1.4 FC
PE/Cyanine7 anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 488 anti-mouse Ly-6C HK1.4 FC
Alexa Fluor® 700 anti-mouse Ly-6C HK1.4 FC
APC/Cyanine7 anti-mouse Ly-6C HK1.4 FC
PerCP anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 570™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 421™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 510™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 605™ anti-mouse Ly-6C HK1.4 FC
Brilliant Violet 711™ anti-mouse Ly-6C HK1.4 FC
Purified anti-mouse Ly-6C (Maxpar® Ready) HK1.4 FC,CyTOF®
Brilliant Violet 785™ anti-mouse Ly-6C HK1.4 FC
PE/Dazzle™ 594 anti-mouse Ly-6C HK1.4 FC
APC/Fire™ 750 anti-mouse Ly-6C HK1.4 FC
TotalSeq™-A0013 anti-mouse Ly-6C HK1.4 PG
Brilliant Violet 650™ anti-mouse Ly-6C HK1.4 FC
TotalSeq™-C0013 anti-mouse Ly-6C HK1.4 PG
TotalSeq™-B0013 anti-mouse Ly-6C HK1.4 PG
APC/Fire™ 810 anti-mouse Ly-6C Antibody HK1.4 FC
Spark Red™ 718 anti-mouse Ly-6C HK1.4 FC
Spark UV™ 387 anti-mouse Ly-6C HK1.4 FC
PE/Fire™ 810 anti-mouse Ly-6C HK1.4 FC
Spark Blue™ 550 anti-mouse Ly-6C (Flexi-Fluor™) HK1.4 FC
Spark Blue™ 574 anti-mouse Ly-6C (Flexi-Fluor™) HK1.4 FC
PE/Cyanine5 anti-mouse Ly-6C HK1.4 FC
Spark PLUS B550™ anti-mouse Ly-6C HK1.4 FC
PerCP/Fire™ 806 anti-mouse Ly-6c Antibody HK1.4 FC
Go To Top Version: 2    Revision Date: 12.09.2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account